Alaunos Therapeutics (TCRT) Interest Coverage Ratio (2011 - 2026)

Alaunos Therapeutics' (TCRT) quarterly Interest Coverage Ratio came in at 53.26 in Q1 2026, up 46.15% on a QoQ basis from 98.92 in Q3 2025.

Alaunos Therapeutics (TCRT) Interest Coverage Ratio (2011 - 2026) Analysis & Trends

Alaunos Therapeutics (TCRT) has 15 years of Interest Coverage Ratio data on file, last reported at 53.26 in Q1 2026.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 53.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 218.16 (down 644.14% YoY) and the FY2025 annual result came in at 0.02, changed N/A from the prior year.
Interest Coverage Ratio rose to 53.26 in Q1 2026, from 98.92 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 0.02 in Q2 2025 to a low of 98.92 in Q3 2025.
A 4-year average of 27.14 and a median of 11.61 in 2022 frame the typical range for Interest Coverage Ratio.
Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 79.43% — and 2023, when it sank 491.26%.
Tracing TCRT's Interest Coverage Ratio over 4 years: stood at 9.47 in 2022, then slumped by 491.26% to 55.98 in 2023, then sank by 76.7% to 98.92 in 2025, then jumped by 46.15% to 53.26 in 2026.
The last three Interest Coverage Ratio figures came in at 53.26 (Q1 2026), 98.92 (Q3 2025), and 0.02 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	117.59
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	8.18
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	2.82
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	76.86
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-0.08
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	1.42
10	Alaunos Therapeutics	4.28 Mn	4.16 Mn	-	-

Download Data